Page 10 - Read Online
P. 10

Tummala et al. Vessel Plus 2022;6:17  https://dx.doi.org/10.20517/2574-1209.2021.114  Page 3 of 15

               Table 1. Preoperative atrial fibrillation rates for surgical aortic valve replacement
                Ref.                      SAVR sample size (n)         Preoperative SAVR AF (%)
                         [7]
                Jørgensen et al.  2017    38                           8 (21.1)
                      [8]
                Leon et al.  2016         1021                         359 (35.2)
                      [9]
                Mack et al.  2019         454                          85 (18.8)
                      [10]
                Smith et al.   2011       351                          30 days: 56 (16.0)
                                                                       1 year: 60 (17.1)
                Takahashi et al. [11]  2014  63                        4 (6.3)
                        [12]
                Bowdish et al.   2016     492                          53 (10.8)
                *Not specific to AS
                       [13]
                Shahim et al.   2021      452                          88 (19.5)
                Reardon et al. [14]  2017  796                         211 (26.5)
               Comparison of preoperative SAVR AF rates. SAVR: Surgical aortic valve replacement; AF: atrial fibrillation; AS: aortic stenosis.

               TAVR
               Pre-existing atrial fibrillation has been reported in 15.7%-48.9% of patients undergoing TAVR [Table 2].
               Furthermore, Tarantini et al.  reported that pre-existing atrial fibrillation has a significantly higher
                                         [5]
               prevalence in TAVR patients treated using the transapical approach than those treated using the
               transfemoral approach (41.8% vs. 32.7%, P < 0.01). The higher rates of preoperative atrial fibrillation in
               TAVR compared to SAVR can be attributed to more comorbidities and a worse clinical profile among
               TAVR patients .
                            [21]

               Cardiac diseases
               While atrial fibrillation in patients undergoing aortic valve replacement is fairly common, it is essential to
               know the prevalence of atrial fibrillation in aortic stenosis and compare this prevalence with the prevalence
               of atrial fibrillation in other similar conditions, such as aortic regurgitation, mitral stenosis, and coronary
               artery disease (CAD), above the normal increase due to aging. Pre-existing atrial fibrillation is seen in 5.0%
               of aortic stenosis patients and a similar 5.8% in aortic regurgitation . Pre-existing atrial fibrillation has
                                                                          [22]
               been seen in 33.9% of patients with mitral valve stenosis, significantly higher than the prevalence rates seen
               in aortic stenosis . While the prevalence of CAD in atrial fibrillation patients is quite high, the rate of atrial
                             [22]
               fibrillation in CAD patients is only around 0.2% to 5% . These low rates are also seen in normal aging, with
                                                            [23]
               a prevalence of atrial fibrillation of 2.3% among people over 40 years and 5.9% among people over 65
                   [24]
               years .

               PREOP AF OUTCOMES
               SAVR
               A significant proportion of patients receiving aortic valve replacement have pre-existing atrial fibrillation.
               Shahim et al.  studied the impact of pre-existing atrial fibrillation on outcomes after aortic valve
                           [13]
               replacement surgery. They found that atrial fibrillation was significantly associated with non-cardiac-related
               death and major complications. Death, stroke, or rehospitalization at 2 years occurred in 24.6% of SAVR
               patients with preexisting atrial fibrillation but only occurred in 15.8% of SAVR patients without
               preoperative AF (OR = 2.22; 95%CI: 1.19-4.13). Further studies are needed to truly understand the impact of
               pre-existing atrial fibrillation in the SAVR specific population.

               TAVR
               Given the prevalence of preoperative atrial fibrillation, several studies have tried to determine the impact of
               baseline atrial fibrillation on post-TAVR outcomes. Short-term 30-day, adverse outcomes like mortality,
               stroke, vascular complications, and repeat hospitalization have been significantly higher in patients with
   5   6   7   8   9   10   11   12   13   14   15